Pure Biologics S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was PLN 4.97 million compared to PLN 7.04 million a year ago. Basic loss per share was PLN 1.49 compared to PLN 2.29 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 PLN | +1.62% |
|
+4.14% | -30.38% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.38% | 72.84L | |
+19.41% | 4.55TCr | |
-8.62% | 3.85TCr | |
+38.65% | 3.81TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- PUR Stock
- News Pure Biologics S.A.
- Pure Biologics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024